Premium
Research supports methylphenidate for ADHD in youths, amphetamines in adults
Publication year - 2018
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30375
Subject(s) - methylphenidate , attention deficit hyperactivity disorder , attention deficit , medicine , psychiatry , psychology , clinical psychology
Findings from a comprehensive systematic review and meta‐analysis of medications to treat attention‐deficit/hyperactivity disorder (ADHD) support methylphenidate as the first‐choice option for the treatment of children and amphetamines as the preferred choice in adults. The findings apply to short‐term treatment with the medications over 12 weeks, as the researchers did not reach conclusive findings for 26‐ and 52‐week timepoints because of a scarcity of data.